India's Sun Pharma to acquire Checkpoint Therapeutics
ReutersMar 10, 2025 2:08 AM
March 10 (Reuters) - India's Sun Pharmaceutical Industries SUN.NS said on Monday that it will acquire Checkpoint Therapeutics CKPT.O, a U.S.-based immunotherapy and targeted oncology company, in a deal valued at up to $355 million.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.TradingKey
Mon, Sep 8
AppLovin Q2 FY2025 Earnings Review: AI-Fueled Surge Delivers Record Results—So Why Did the Stock Dip After Hours?
TradingKey - AppLovin (NASDAQ: APP) reported strong Q2 FY2025 earnings on August 6, 2025, driven by its AI-powered advertising platform, Axon 2.0, and the completion of its apps business divestiture. The company exceeded market expectations, although cautious guidance, concerns over long-term impactTradingKey
Thu, Aug 7
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.TradingKey
Mon, Jul 14
Oracle's Cloud Revenue Jumps 27% in Its Fiscal 2025 Q4
Oracle (NYSE:ORCL) reported its fiscal 2025 fourth-quarter results on June 11, delivering quarterly revenue of $15.9 billion (up 11%) and annual revenue of $57.4 billion (up 9%), surpassing earlier guidance. It also raised its fiscal 2026 revenue target to over $67 billion, forecasting 16% growth...The Motley Fool
Thu, Jun 12
[IN-DEPTH ANALYSIS] Riding the Wave: How Medtronic Capitalizes on the Aging Population
TradingKey - Against the backdrop of the global aging trend and the continuous rise in the incidence of chronic diseases, Medtronic's product portfolio precisely meets the growing demand for diagnosis and treatment. Relying on its global supply chain network and years of accumulated technological...TradingKey
Mon, May 26
.jpg)
Tradingkey
